Offer - Urjas Oil for just ₹ 1 X
Velcade 3.5 Injection is a prescription medicine that is available as a Injection. Multiple Myeloma are some of its major therapeutic uses. Other than this, Velcade 3.5 Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Velcade 3.5 Injection is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Velcade 3.5 Injection can also lead to other problems, which have been listed below. Usually, these side effects of Velcade 3.5 Injection go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Velcade 3.5 Injection's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Velcade 3.5 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Velcade 3.5 Injection is contraindicated in people with pre-existing medical conditions like Gastrointestinal Bleeding as it can result in adverse effects. The section on Velcade 3.5 Injection contraindications lists all such conditions.
Drug interactions for Velcade 3.5 Injection have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Velcade 3.5 Injection is not safe while driving, and is not addiction.
Velcade 3.5 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Velcade 3.5 Injection safe for pregnant women?
Pregnant women may get severe side effects after taking Velcade. If you are pregnant, do not take Velcade without a doctor's advice.
Is the use of Velcade 3.5 Injection safe during breastfeeding?
Velcade should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Velcade 3.5 Injection on the Kidneys?
Velcade does not damage the kidneys.
What is the effect of Velcade 3.5 Injection on the Liver?
The liver can be affected by Velcade. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Velcade only after medical advice.
What is the effect of Velcade 3.5 Injection on the Heart?
You may experience side effects on your heart after taking Velcade. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Velcade 3.5 Injection unless your doctor advises you to do so -
Is this Velcade 3.5 Injection habit forming or addictive?
Velcade 3.5 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Velcade 3.5 Injection as you may feel sleepy.
Is it safe?
Yes, but take Velcade 3.5 Injection only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Velcade 3.5 Injection for mental disorders.
Interaction between Food and Velcade 3.5 Injection
Eating certain foods may increase the time it takes Velcade 3.5 Injection to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Velcade 3.5 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Velcade 3.5 Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 234-235
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 871
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Velcade® (bortezomib)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Bortezomib Aft (Bortezomib)